CSIMarket
 


Immune Therapeutics Inc  (IMUN)
Other Ticker:  
 

Cumulative Immune Therapeutics Inc's Quick Ratio for Trailing Twelve Months Period

IMUN's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

IMUN Quick Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth -73.22 % -37.12 % 5.1 % -5.05 % -7.06 %
Y / Y Cash & cash equivalent Growth 550.48 % 1069.59 % 3567.94 % 4755.82 % -5.72 %
Quick Ratio for Trailing Twelve Months Period 0.04 0.03 0.02 0.01 0
Total Ranking # 3812 # 5079 # 5232 # 5643 # 4645
Seq. Current Liabilities Growth -59.17 % -39.48 % 1.96 % 6.31 % -4.14 %
Seq. Cash & cash equivalent Growth -29.68 % -37.85 % -11.54 % 1582.46 % 26.44 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Immune Therapeutics Inc Cash & cash equivalent average more than doubled by 550.48 % in III. Quarter year on year, while Current Liabilities dropped to $3 millions, this led to increase in in Immune Therapeutics Inc's Quick Ratio for Trailing Twelve Months Period to 0.04, Quick Ratio for Trailing Twelve Months Period remained below Immune Therapeutics Inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 492 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Immune Therapeutics Inc. While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 3812, from total ranking in previous quarter at 5079.

What is Quick Ratio?
Learn more about IMUN
Quick Ratio IMUN in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 493
Sector # 1010
S&P 500 # 3801


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.04 0.01 0
(Sep 30 2022)   (Mar 31 2019)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Theralink Technologies Inc   0.12 
International Stem Cell Corporation  0.11 
Axim Biotechnologies Inc   0.10 
Bioxytran Inc   0.09 
Rebus Holdings Inc   0.09 
Rapid Therapeutic Science Laboratories Inc   0.08 
Evofem Biosciences Inc   0.08 
Viatris Inc   0.08 
Arctos Northstar Acquisition Corp   0.08 
Agex Therapeutics Inc   0.08 
Cure Pharmaceutical Holding Corp   0.07 
Integrated Biopharma Inc  0.06 
Khosla Ventures Acquisition Co   0.06 
Cytodyn inc   0.05 
Northwest Biotherapeutics inc  0.05 
Bespoke Extracts Inc.  0.04 
Provectus Biopharmaceuticals Inc   0.04 
Bioadaptives Inc   0.04 
Sunwin Stevia International Inc.  0.03 
Immune Therapeutics Inc  0.03 
Skinvisible Inc.  0.03 
Q Biomed inc   0.03 
Regen Biopharma Inc   0.02 
Landec Corporation  0.02 
Oncotelic Therapeutics Inc   0.02 
Kaya Holdings Inc  0.02 
Musclepharm Corporation  0.02 
Adhera Therapeutics Inc   0.02 
Sangui Biotech International Inc  0.02 
American Bio Medica Corporation  0.01 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ARMK's Profile

Stock Price

ARMK's Financials

Business Description

Fundamentals

Charts & Quotes

ARMK's News

Suppliers

ARMK's Competitors

Customers & Markets

Economic Indicators

ARMK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071